• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学内照射剂量学(MIRD)评论:适用于确定性生物效应的剂量学单位的建议名称——巴伦森(Bd)。

MIRD commentary: proposed name for a dosimetry unit applicable to deterministic biological effects--the barendsen (Bd).

作者信息

Sgouros George, Howell Roger W, Bolch Wesley E, Fisher Darrell R

机构信息

Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, USA.

出版信息

J Nucl Med. 2009 Mar;50(3):485-7. doi: 10.2967/jnumed.108.057398.

DOI:10.2967/jnumed.108.057398
PMID:19258259
Abstract

The fundamental physical quantity for relating all biologic effects to radiation exposure is the absorbed dose, the energy imparted per unit mass of tissue. Absorbed dose is expressed in units of joules per kilogram (J/kg) and is given the special name gray (Gy). Exposure to ionizing radiation may cause both deterministic and stochastic biologic effects. To account for the relative effect per unit absorbed dose that has been observed for different types of radiation, the International Commission on Radiological Protection (ICRP) has established radiation weighting factors for stochastic effects. The product of absorbed dose in Gy and the radiation weighting factor is defined as the equivalent dose. Equivalent dose values are designated by a special named unit, the sievert (Sv). Unlike the situation for stochastic effects, no well-defined formalism and associated special named quantities have been widely adopted for deterministic effects. The therapeutic application of radionuclides and, specifically, alpha-particle emitters in nuclear medicine has brought to the forefront the need for a well-defined dosimetry formalism applicable to deterministic effects that is accompanied by corresponding special named quantities. This commentary reviews recent proposals related to this issue and concludes with a recommendation to establish a new named quantity.

摘要

将所有生物效应与辐射暴露相关联的基本物理量是吸收剂量,即单位质量组织所吸收的能量。吸收剂量的单位是焦耳每千克(J/kg),并赋予了专门名称戈瑞(Gy)。暴露于电离辐射可能会导致确定性和随机性生物效应。为了考虑不同类型辐射每单位吸收剂量的相对效应,国际放射防护委员会(ICRP)已为随机性效应确定了辐射权重因子。以戈瑞为单位的吸收剂量与辐射权重因子的乘积定义为当量剂量。当量剂量值由一个专门的命名单位希沃特(Sv)表示。与随机性效应的情况不同,对于确定性效应,尚未广泛采用明确的形式体系和相关的专门命名量。放射性核素,特别是α粒子发射体在核医学中的治疗应用,凸显了对适用于确定性效应的明确剂量学形式体系以及相应专门命名量的需求。本评论回顾了与该问题相关的近期提议,并以建议设立一个新的命名量作为结论。

相似文献

1
MIRD commentary: proposed name for a dosimetry unit applicable to deterministic biological effects--the barendsen (Bd).医学内照射剂量学(MIRD)评论:适用于确定性生物效应的剂量学单位的建议名称——巴伦森(Bd)。
J Nucl Med. 2009 Mar;50(3):485-7. doi: 10.2967/jnumed.108.057398.
2
Radiation doses and risks from internal emitters.体内辐射源的辐射剂量与风险。
J Radiol Prot. 2008 Jun;28(2):137-59. doi: 10.1088/0952-4746/28/2/R01. Epub 2008 May 22.
3
MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.医学内部辐射剂量学第21号手册:放射性药物剂量测定的通用模式——术语标准化
J Nucl Med. 2009 Mar;50(3):477-84. doi: 10.2967/jnumed.108.056036.
4
Dose quantities in radiation protection and their limitations.辐射防护中的剂量量及其限制。
Radiat Prot Dosimetry. 2004;112(4):457-63. doi: 10.1093/rpd/nch097.
5
Sievert, gray and dose equivalent.希沃特、戈瑞与剂量当量。
J Can Assoc Radiol. 1983 Dec;34(4):298-300.
6
The ICRP protection quantities, equivalent and effective dose: their basis and application.国际放射防护委员会的防护量、当量剂量和有效剂量:其基础与应用。
Radiat Prot Dosimetry. 2007;127(1-4):12-8. doi: 10.1093/rpd/ncm248. Epub 2007 Nov 14.
7
The ICRU (International Commission on Radiation Units and Measurements): its contribution to dosimetry in diagnostic and interventional radiology.国际辐射单位与测量委员会(ICRU):其对诊断和介入放射学剂量测定的贡献。
Radiat Prot Dosimetry. 2005;117(1-3):7-12. doi: 10.1093/rpd/nci701. Epub 2006 Feb 3.
8
Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.相对生物效应(RBE)、品质因数(Q)和辐射权重因数(w(R))。国际放射防护委员会报告。
Ann ICRP. 2003;33(4):1-117. doi: 10.1016/s0146-6453(03)00024-1.
9
Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations.基于国际辐射防护委员会/国际辐射单位与测量委员会修订建议的中子有效品质因数
Radiat Prot Dosimetry. 2005;115(1-4):536-41. doi: 10.1093/rpd/nci004.
10
The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units.离子束治疗中的相对生物效应问题:国际原子能机构/国际辐射单位与测量委员会联合工作组关于量和单位的结论
Radiat Prot Dosimetry. 2006;122(1-4):463-70. doi: 10.1093/rpd/ncl447. Epub 2007 Jan 17.

引用本文的文献

1
A mathematical model for the investigation of combined treatment of radiopharmaceutical therapy and PARP inhibitors.一种用于研究放射性药物治疗与PARP抑制剂联合治疗的数学模型。
Eur J Nucl Med Mol Imaging. 2025 Feb 20. doi: 10.1007/s00259-025-07144-y.
2
Head-to-head comparison of three chelates reveals DOTAGA promising for Ac labeling of anti-FZD10 antibody OTSA101.三种螯合剂的头对头比较表明 DOTAGA 有望用于抗 FZD10 抗体 OTSA101 的 Ac 标记。
Cancer Sci. 2023 Dec;114(12):4677-4690. doi: 10.1111/cas.15978. Epub 2023 Oct 2.
3
FZD10-targeted α-radioimmunotherapy with Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model.
FZD10 靶向α-放射性免疫治疗联合 Ac 标记的 OTSA101 在滑膜肉瘤模型中实现完全缓解。
Cancer Sci. 2022 Feb;113(2):721-732. doi: 10.1111/cas.15235. Epub 2021 Dec 21.
4
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of Ac-PSMA (Prostate-Specific Membrane Antigen).转移性去势抵抗性前列腺癌(mCRPC)患者的靶向α治疗:锕-前列腺特异性膜抗原(Ac-PSMA)的预测剂量测定与毒性建模
Front Oncol. 2020 Nov 5;10:531660. doi: 10.3389/fonc.2020.531660. eCollection 2020.
5
Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.剂量学、放射生物学和合成致死性:放射性药物治疗 (RPT) 与α粒子发射器。
Semin Nucl Med. 2020 Mar;50(2):124-132. doi: 10.1053/j.semnuclmed.2019.11.002. Epub 2020 Feb 26.
6
Appropriate Use of Effective Dose in Radiation Protection and Risk Assessment.有效剂量在辐射防护与风险评估中的合理应用。
Health Phys. 2017 Aug;113(2):102-109. doi: 10.1097/HP.0000000000000674.
7
Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.用发射电子的放射性核素对肿瘤和正常细胞进行靶向治疗后的存活情况。
Med Phys. 2013 Jan;40(1):014101. doi: 10.1118/1.4769409.
8
Modelling and dosimetry for alpha-particle therapy.α粒子治疗的建模与剂量测定
Curr Radiopharm. 2011 Jul;4(3):261-5. doi: 10.2174/1874471011104030261.
9
21 years of biologically effective dose.21 年的生物有效剂量。
Br J Radiol. 2010 Jul;83(991):554-68. doi: 10.1259/bjr/31372149.
10
The BJR and progress in radiobiological modelling.《英国放射学杂志》与放射生物学建模的进展。
Br J Radiol. 2010 Jul;83(991):544-5. doi: 10.1259/bjr/52885245.